Navigenics announced last week that Mari Baker, president and CEO of the company since its inception in 2007, would step down from her post to pursue other opportunities.
The company's board of directors "is actively interviewing candidates for the president and CEO position," Navigenics said in a statement. In the meantime, board members Dana Mead and Sue Siegel will work together with the existing executive team to lead the company.
Baker's departure occurred this week. She will continue to serve as a board.
Illumina CEO Jay Flatley has joined the board of directors of Helixis, a developer of nucleic acid analysis tools. Prior to joining Illumina, Flatley was president and CEO of Molecular Dynamics, now part of GE Healthcare, and led that company's initial public offering in 1993.